SCHEMBL7184399

SCHEMBL7184399

CC=CCc1cc(CC=CC)c(OC(C)C)c(C=CC(=O)c2ccc(NC)cc2)c1O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.36
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
HPGD P15428 1/20 0.33
PTPN1 P18031 1/20 0.32
CTSL P07711 1/20 0.32
CTSB P07858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184394 1.00 CYP3A4 (0.36) CYP3A4KDM4EMEN1ALDH1A1GAA
SCHEMBL7184363 0.90 PTPN1 (0.39) MEN1ALDH1A1MAPTKMT2AABCG2
SCHEMBL7184359 0.90 PTPN1 (0.39) MEN1ALDH1A1MAPTKMT2AABCG2
SCHEMBL7186019 0.89 PTPN1 (0.42) CYP3A4PTPN1
SCHEMBL7186016 0.89 PTPN1 (0.42) CYP3A4PTPN1
SCHEMBL7187815 0.89 ABCG2 (0.40) CYP3A4KDM4EMEN1ALDH1A1GAA
SCHEMBL7191691 0.89 CA1 (0.41) CYP3A4MEN1ALDH1A1MAPTKMT2A
SCHEMBL7187810 0.89 ABCG2 (0.40) CYP3A4KDM4EMEN1ALDH1A1GAA
SCHEMBL7191694 0.89 CA1 (0.41) CYP3A4MEN1ALDH1A1MAPTKMT2A
SCHEMBL7186120 0.88 CYP3A4 (0.38) CYP3A4KDM4EMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed